Stem Cell Therapy in Sarasota: What to Know and 7 Questions to Ask Before a Consultation
Stem cell therapy is one of the most talked-about topics in pain management, orthopedics, mobility care, and regenerative medicine. It is also one of the most confusing.
Some patients hear that stem cells may help the body repair tissue. Others see ads about knee pain, back pain, arthritis, disc problems, tendon injuries, neuropathy, or wellness. Some people are told a product is "FDA registered" or "natural" and assume that means it is proven or FDA-approved for their condition.
The truth is more specific. A consultation should not start with a promise. It should start with a careful conversation about your diagnosis, goals, the product or procedure being discussed, the evidence for your condition, the risks, the FDA status, the Florida legal requirements, the cost, and the alternatives.
Educational note: This article is for educational purposes only. It does not replace medical advice, diagnosis, treatment, legal advice, or an individualized evaluation by a qualified healthcare professional.
Florida stem-cell therapy notice:
THIS NOTICE MUST BE PROVIDED TO YOU UNDER FLORIDA LAW. This physician performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care provider before undergoing any stem cell therapy.
Key Takeaways Before You Keep Reading
- "Stem cell therapy" is not one single treatment. The phrase may refer to different cell sources, tissue products, preparation methods, and clinical uses.
- FDA approval is product-specific and use-specific. A product may be approved for one use and not approved for another.
- Many regenerative products marketed for orthopedic, pain, joint, mobility, or wellness concerns are not FDA-approved for those uses. FDA consumer guidance specifically warns patients about unapproved regenerative medicine products marketed for orthopedic conditions and other concerns.
- Florida has a statutory framework for certain physician-performed stem-cell therapies. Florida availability does not mean the therapy is FDA-approved or proven effective for a particular condition.
- The evidence for many orthopedic and pain uses is still developing. Some studies report symptom improvement, but patients should be cautious with claims about cartilage regrowth, nerve reversal, or arthritis cures.
- A responsible consultation should include risks, alternatives, realistic goals, and a follow-up plan. It should also leave room for the answer: "This is not recommended for you."
What Does "Stem Cell Therapy" Actually Mean?
A stem cell is a cell that can self-renew and can develop into certain more specialized cells. Stem-cell-based treatments are already used in some specific, well-established settings, especially blood and immune system disorders treated with blood-forming stem cell transplantation.
In everyday marketing, though, "stem cell therapy" is often used much more loosely. It may refer to several different products, procedures, or categories of regenerative medicine.
- Stem-cell therapy: A broad phrase for treatments that use stem cells, cells derived from stem cells, or products claimed to contain stem cells. Ask what exact product or procedure is being discussed.
- Autologous cells: Cells or tissue taken from your own body. Ask where they are taken from, how they are processed, and whether they are used the same day.
- Allogeneic cells or tissue: Cells or tissue from a donor. Ask about donor screening, testing, tracking, and product documentation.
- Bone marrow aspirate concentrate, or BMAC: Bone marrow drawn from the patient and concentrated. It may contain a mixture of cells and growth factors.
- Fat or adipose-derived products: Products derived from fat tissue. Ask whether the product is minimally manipulated and what FDA status applies to the proposed use.
- Perinatal or birth-tissue products: Products derived from sources such as umbilical cord tissue, cord blood, amniotic tissue, or Wharton's jelly. Ask whether the product contains live cells, where it comes from, and what documentation is available.
- Exosomes: Small particles released by cells and often marketed as regenerative products. FDA consumer guidance states there are currently no FDA-approved exosome products.
- PRP: Platelet-rich plasma made from your blood. PRP is often discussed under regenerative medicine, but it is not stem-cell therapy.
- Orthobiologics: A broad orthopedic term for biologic products such as PRP, bone marrow concentrate, tissue products, and other materials.
The name matters because different products have different evidence, risks, regulatory status, preparation methods, and costs.
Seven Questions to Ask Before a Stem-Cell Consultation
1. What diagnosis are we actually treating?
Pain is a symptom, not a diagnosis. Knee pain may come from osteoarthritis, meniscus injury, ligament injury, tendon problems, inflammation, referred pain, or more than one cause. Back pain may involve discs, joints, nerves, muscles, posture, spinal stenosis, prior injury, or other factors.
Ask:
- What diagnosis are we evaluating?
- What exam findings, imaging, or records matter?
- Are there other possible causes of my symptoms?
- Is this condition one where stem-cell therapy has evidence?
- What would make you recommend something else?
A good evaluation should not jump straight from "I have pain" to "you need stem cells."
2. Am I a candidate, and why or why not?
Stem-cell therapy should not be a one-size-fits-all service. Candidacy may depend on your diagnosis, severity, overall health, medications, prior care, functional goals, risk factors, and whether other options should be tried first.
Ask:
- Who determines candidacy?
- What information do you use to decide?
- What would make me a poor candidate?
- Are there health conditions or medications that increase risk?
- If I am not a candidate, what are my next best options?
A trustworthy consultation should be comfortable saying "not recommended" when appropriate.
3. What exact product or procedure are we discussing?
You should not have to guess what is being used. Ask for plain language and documentation.
Ask:
- Is this autologous, meaning from my own body, or allogeneic, meaning from a donor?
- What is the tissue source?
- Is it bone marrow, adipose tissue, cord blood, umbilical cord tissue, Wharton's jelly, amniotic tissue, exosomes, PRP, or something else?
- Is it a live-cell product?
- How is it collected, processed, stored, thawed, prepared, and tracked?
- What facility manufactured or processed it?
- What certification or accreditation applies?
- Is there lot-specific documentation, sterility information, and a viability report when required?
- Will I receive copies of relevant consent and product information?
The more specific the answer, the easier it is to evaluate the recommendation.
4. Is it FDA-approved for my specific use?
This question should be answered directly.
Ask:
- Is this product FDA-approved for my diagnosis?
- If yes, what is the product name, manufacturer, and approved indication?
- If not, is it being offered under Florida's stem-cell therapy law, an FDA-authorized clinical trial, expanded access, or another pathway?
- Is there an Investigational New Drug application or other FDA oversight?
- Is there Institutional Review Board oversight if it is research?
- Does the consent form clearly state whether the therapy is FDA-approved for my condition?
Do not accept "FDA registered" as a substitute for "FDA-approved for this use."
5. What results are realistic, and how will we measure them?
A consultation should focus on realistic goals, not dramatic promises.
Ask:
- What improvement is realistic for someone like me?
- Are we trying to reduce pain, improve function, delay surgery, support rehabilitation, or something else?
- How long might it take to know whether care is helping?
- How will progress be measured?
- What happens if I do not improve?
- Is there evidence that this treatment changes the structure of the joint or tissue, or is the goal symptom relief?
For many orthopedic conditions, symptom improvement and tissue regeneration are not the same thing. Ask the clinician to separate those claims.
6. What risks, alternatives, and follow-up should I understand?
Informed consent should include benefits, risks, alternatives, and the option of no treatment.
Ask:
- What are the most common risks?
- What are the serious but less common risks?
- What risks apply to my health history?
- What alternatives should I compare?
- What happens if I choose no treatment right now?
- Should I speak with my primary care provider, orthopedist, pain specialist, or another clinician before deciding?
- What follow-up visits are included?
- Who handles complications?
A good plan should include what happens before, during, and after the procedure.
7. What will it cost, and what is included?
Many regenerative medicine services are not covered by insurance, especially when evidence is limited or the treatment is considered experimental or investigational. Costs can vary by product, procedure, imaging, follow-up, and rehabilitation plan.
Ask:
- What is the full cost?
- What is included?
- Are imaging, labs, consultation, procedure, follow-up, or rehabilitation billed separately?
- Is any part covered by insurance?
- Is there a refund or outcome guarantee? If so, what exactly does it mean?
- How does the cost compare with other evidence-based options?
A medical decision is also a financial decision. You deserve clear numbers before proceeding.
What to Bring to Your Consultation
Bring or prepare:
- A list of your main symptoms and when they started
- Your top functional goals, such as walking farther, climbing stairs, returning to activity, or reducing medication use
- Prior imaging reports or discs, if available
- Prior treatment records
- A list of medications and supplements
- Your medical history, including infections, immune problems, cancer history, bleeding disorders, or surgeries
- Questions about FDA status, Florida law, product source, risks, alternatives, follow-up, and cost
- Contact information for your primary care provider or relevant specialists
You do not need to know every answer before the visit. The purpose of the consultation is to clarify whether any specific option makes sense.
Red Flags to Watch For
Be cautious if you encounter:
- Guaranteed results
- Claims that one product treats many unrelated diseases
- Claims of cartilage regrowth, nerve reversal, or cure without strong evidence
- Heavy reliance on testimonials instead of data
- Pressure to pay or schedule immediately
- No physician evaluation
- No review of diagnosis, imaging, or prior treatment
- No written informed consent
- Vague product names or no documentation
- "FDA registered" used as if it means FDA-approved
- No discussion of alternatives
- No discussion of serious risks
- No follow-up plan
- No clear contact plan if something goes wrong
A careful clinic should welcome questions.
What to Expect at Platinum Healthcare Sarasota
If you request an evaluation at Platinum Healthcare's Sarasota office, the first step should be an evaluation, not a promise of treatment.
The clinical team can review your symptoms, health history, prior care, imaging or records, functional goals, and questions. The goal is to determine whether stem cell therapy, regenerative cellular medicine, rehabilitation, chiropractic care, medical pain relief, spinal decompression, referral, continued conservative care, or another option may be appropriate to discuss.
If stem-cell therapy is not a fit, that should be part of an honest conversation. The right plan depends on your diagnosis, goals, risk factors, and the evidence for your situation.
FAQ: Stem Cell Therapy in Sarasota
Is stem-cell therapy FDA-approved?
Sometimes, for very specific products and uses. FDA-approved cellular and gene therapy products exist, but approval is product-specific and condition-specific. Many products marketed for orthopedic, pain, joint, mobility, or wellness uses are not FDA-approved for those uses.
Does Florida allow stem-cell therapy?
Florida has a statutory framework for certain physician-performed stem-cell therapies that have not yet been approved by the FDA, when they are within the physician's scope of practice and related to orthopedics, wound care, or pain management. Patients should still ask about FDA status, evidence, product documentation, risks, alternatives, and informed consent.
Does "available in Florida" mean "FDA-approved"?
No. Florida availability does not mean FDA approval. Ask directly whether the specific product and use are FDA-approved.
Are exosomes FDA-approved?
FDA consumer guidance states that there are currently no FDA-approved exosome products. Ask any clinic offering exosomes to explain the exact product, legal pathway, evidence, risks, and FDA status.
Can stem-cell therapy regrow cartilage?
Be cautious with cartilage-regrowth claims. Some cell-based approaches are being studied, and certain FDA-approved cellular products exist for narrow indications such as specific knee cartilage defects. That is not the same as saying a marketed stem-cell injection regrows cartilage or cures arthritis. Ask what evidence supports the claim for your exact diagnosis and product.
Is stem-cell therapy proven for knee arthritis or hip arthritis?
Evidence remains limited and mixed. Some studies report symptom improvement, but preparations vary and strong evidence is lacking for many uses. The American College of Rheumatology and Arthritis Foundation guideline recommended against stem cell injections for knee and hip osteoarthritis because of limited standardization in preparations and techniques.
Is stem-cell therapy covered by insurance?
Many regenerative medicine procedures are not covered when they are considered experimental, investigational, or not medically necessary under a plan's policy. Ask the clinic and your insurer what is covered, what is cash-pay, and what follow-up costs may apply.
What if I am not a candidate?
That can be a good outcome if it prevents unnecessary risk or cost. Depending on your situation, other options may include rehabilitation, activity modification, weight-management support, medications, injections with stronger evidence, chiropractic care, spinal decompression, pain-management options, orthopedic evaluation, continued monitoring, or no procedure at this time.
Should I talk to my primary care provider first?
Florida's statutory notice encourages patients to consult with their primary care provider before undergoing stem-cell therapy. This is especially important if you have chronic medical conditions, take blood thinners or immune-related medications, have a history of cancer or infection, or are considering an expensive procedure with uncertain benefit.
Interested in Learning More?
If you are considering stem-cell therapy in Sarasota, give Platinum Healthcare a call to explore whether a consultation may be appropriate for your goals and symptoms. Our Sarasota team can help you understand the next step and what questions to ask before making a decision.
Call Platinum Healthcare at 941-927-1123 or contact our Sarasota office to learn more.
Sources
- FDA Consumer Alert on regenerative medicine products including stem cells and exosomes
- FDA Important Patient and Consumer Information About Regenerative Medicine Therapies
- FDA Approved Cellular and Gene Therapy Products
- Florida Statutes Section 458.3245, Stem cell therapy
- Florida Statutes Section 459.0127, Stem cell therapy
- American Academy of Orthopaedic Surgeons: Use of Stem Cells in Orthopaedics
- International Society for Stem Cell Research Clinical Resources
- American College of Rheumatology / Arthritis Foundation osteoarthritis guideline announcement